Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation (scientific article published on 01 April 1966)

Q66903513	A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis
Q36635652	Drug therapy of tuberculosis
Q67313403	Ethambutol and intra-ocular pressure
Q28270240	Extensively drug-resistant tuberculosis in a young child after travel to India
Q35657670	Intermittent Versus Daily Pulmonary Tuberculosis Treatment Regimens: A Meta-Analysis
Q72400103	Modern management of tuberculosis
Q39890037	Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
Q36461593	Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis
Q42238394	Toxic amblyopia due to ethambutol in a case of drug resistant pulmonary tuberculosis
Q28361874	Toxic ocular effects of ethambutol
Q42281128	Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.
Q28362236	Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy
Q67276615	[Results of daily-oral therapy with ethambutol and isoniazid in tuberculosis (author's transl)]

P356	DOI	10.1111/J.1749-6632.1966.TB45526.X
P953	full work available at URL	https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1966.tb45526.x
		https://nyaspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1749-6632.1966.tb45526.x
P698	PubMed publication ID	5220243